Minneapolis. Clinical Pharmacology Excellence in the U.S.
Our U.S. flagship site in the heart of Medical Alley delivers fast, FDA-aligned early-phase trials, with industry-leading renal impairment capabilities and patient recruitment infrastructure.
Your U.S. Partner for complex early-phase studies
Located in the globally recognized Medical Alley region, Nucleus Network Minneapolis is a purpose-built clinical pharmacology unit specializing in First-in-Human, renal impairment, and special population studies.
With dedicated dialysis infrastructure, seasoned medical leadership, and fully FDA-compliant operations, the site offers everything needed to run complex trials safely and efficiently, while supporting integrated programs across our Australian locations.
Fast facts
54
Beds
University Enterprise Labs, Medical Alley, MN
Co-Location
Renal & hepatic impairment, FIH (healthy & patient), DDI
Specialties
Onsite Dialysis
FDA- and EMA-inspected
Certifications
50,000+ active volunteer and patient leads
Participant Access
Purpose-built for regulatory alignment and clinical complexity
- Start in AUS while the IND is prepared
- Located near major academic centers and health systems
- Proven experience in SAD/MAD, renal and hepatic trials, food effect, and TQT
- U.S.-based PIs with strong FDA familiarity
- Seamless integration with your global program design
- In-house call center and targeted marketing for patient cohorts
Clinical pharmacology across diverse indications
- Renal & hepatic impairment
- Drug-drug interaction
- First-in-Human (healthy & patient)
- Metabolic & endocrine
- Vaccines & infectious disease
- QTc and TQT studies
- Complex Clinical Pharmacology
- Proof-of-concept (POC) cohorts
Bridge studies between the U.S. and Australia
Nucleus Network Minneapolis works hand-in-hand with our Australian sites to support:
- IND-readiness and data alignment
- Conduct SAD in AUS and MAD or POC in the USA
- Parallel or staged study designs across regions
- Harmonized SOPs and unified leadership across countries
- Flexible program strategies to suit sponsor and regulatory needs
Ready to run your next U.S. trial with confidence?
With in-house dialysis, experienced FDA-facing teams, and high-performing clinical operations, Nucleus Network Minneapolis is built for complex early-phase trials. Let’s move your study forward, faster.
